Blood Group Typing Market Report
Published Date: 22 April 2026 | Report Code: blood-group-typing
Blood Group Typing Market Size, Share, Industry Trends and Forecast to 2033
This report provides a comprehensive analysis of the Blood Group Typing market from 2023 to 2033, covering market size, growth trends, technological advancements, and competitive landscape, including forecasts to identify the potential growth areas and market dynamics.
Key Takeaways
- $5.60 Billion market size in 2023 expanding to $11.45 Billion by 2033 under a 7.2% CAGR.
- North America is both the largest and the fastest-growing region, led by strong hospital and blood bank demand.
- Automated and molecular typing uptake, plus improved reagents and kits, underpin technology-driven market expansion.
- Hospitals, laboratories and blood banking institutions remain primary end users sustaining steady procurement of typing systems.
- Leading vendors include Abbott Laboratories, Thermo Fisher Scientific Inc., Beckman Coulter Inc., and Grifols S.A.
Blood Group Typing Market Report — Executive Summary
The Blood Group Typing Market Report tracks a market that stood at $5.60 Billion in 2023 and is projected to reach $11.45 Billion by 2033, growing at a 7.2% CAGR from 2023 to 2033. Growth is propelled by heightened emphasis on blood safety, higher donor volumes, and broader adoption of automated and molecular typing methods that increase accuracy and throughput. Demand from hospitals, blood banks and forensic laboratories drives procurement of reagents, kits and instrument platforms. Regional dynamics favor North America as the largest and fastest-growing market, supported by advanced diagnostic infrastructure. Market structure comprises type (manual, automated, reagents and kits), application (blood banks, clinical diagnostics, forensic science), and end users (hospitals, laboratories, blood banking institutions). Competitive activity centers on product innovation and partnerships; notable firms listed include Abbott Laboratories, Thermo Fisher Scientific Inc., Beckman Coulter Inc., and Grifols S.A.
Key Growth Drivers
- Rising awareness of blood safety increases routine and donor-related testing demand in hospitals and blood banks.
- Adoption of automated blood typing instruments improves workflow efficiency and reduces manual errors in clinical labs.
- Expansion of molecular typing techniques supports demand for advanced reagents, kits and specialist services.
- Growth of diagnostic infrastructure and blood banking capacity in developed regions, especially North America.
- Ongoing product development and vendor partnerships accelerate availability of integrated typing solutions.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $5.60 Billion |
| CAGR (2023-2033) | 7.2% |
| 2033 Market Size | $11.45 Billion |
| Top Companies | Abbott Laboratories, Thermo Fisher Scientific Inc., Beckman Coulter Inc., Grifols S.A. |
| Last Modified Date | 22 April 2026 |
Blood Group Typing Market Overview
Customize Blood Group Typing Market Report market research report
- ✔ Get in-depth analysis of Blood Group Typing market size, growth, and forecasts.
- ✔ Understand Blood Group Typing's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Blood Group Typing
What is the Market Size & CAGR of Blood Group Typing Market Report market in 2023?
Blood Group Typing Industry Analysis
Blood Group Typing Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Blood Group Typing Market Report Market Analysis Report by Region
Europe Blood Group Typing Market Report:
Europe’s market expands from $1.79 Billion in 2023 to $3.67 Billion in 2033. Regional drivers include established blood banking systems, regulatory emphasis on transfusion safety, and uptake of improved reagents and kits in clinical diagnostics.Asia Pacific Blood Group Typing Market Report:
Asia Pacific grows from $1.05 Billion in 2023 to $2.15 Billion in 2033. Increasing healthcare capacity, rising donor programs and gradual adoption of automated and molecular methodologies are key contributors to market expansion.North America Blood Group Typing Market Report:
North America is identified as both the largest and fastest-growing region, rising from $2.09 Billion in 2023 to $4.27 Billion in 2033. Growth reflects strong hospital procurement, advanced diagnostic infrastructure and early adoption of automated and molecular typing platforms.South America Blood Group Typing Market Report:
Middle East & Africa Blood Group Typing Market Report:
Middle East and Africa advance from $0.3 Billion in 2023 to $0.61 Billion in 2033. Growth drivers include investments in diagnostic capabilities, rising focus on blood safety and incremental adoption of more efficient typing technologies.Tell us your focus area and get a customized research report.
Research Methodology
Blood Group Typing Market Analysis By Type
The Blood Group Typing market, by type, includes Manual Blood Group Typing, Automated Blood Group Typing, and Reagents & Kits. As of 2023, Manual Blood Group Typing holds a significant market size of USD 3.68 billion, and is expected to reach USD 7.53 billion by 2033, reflecting its dominant market share. Automated methods are gaining traction, projected to grow from USD 1.21 billion in 2023 to USD 2.48 billion by 2033, indicating a trend towards efficiency. Meanwhile, the Reagents and Kits segment is also on the rise, growing from USD 0.70 billion in 2023 to USD 1.44 billion by 2033.
Blood Group Typing Market Analysis By Application
In the application domain, Hospitals represent the largest segment, accounting for USD 3.68 billion in 2023, with consistent growth projected to USD 7.53 billion by 2033. Laboratories and Blood Banking Institutions are also significant contributors, showing projected increases from USD 1.21 billion to USD 2.48 billion and from USD 0.70 billion to USD 1.44 billion, respectively, reflecting the essential role of diagnostics in patient care.
Blood Group Typing Market Analysis By End User
End-user segmentation shows a strong market for Blood Banks and Clinical Diagnostics. Blood Banks account for a substantial share, with a projected growth from USD 3.68 billion in 2023 to USD 7.53 billion by 2033, demonstrating the critical need for reliable blood typing. Clinical Diagnostics is estimated to rise alongside, increasing from USD 1.21 billion to USD 2.48 billion during the same period, reflective of the advancing healthcare landscape.
Blood Group Typing Market Analysis By Region Application
Technologically, the market indicates a shift towards Molecular Typing and Serological Typing, which are gaining prominence for their accuracy and speed. Molecular Typing is expected to expand from USD 4.73 billion in 2023 to USD 9.68 billion by 2033, driven by innovations in diagnostics, while Serological Typing shows steady growth anticipated from USD 0.87 billion to USD 1.77 billion.
Blood Group Typing Market Analysis By Selling Channel
The market by selling channel indicates a large share from Direct Sales, projected to grow from USD 4.73 billion in 2023 to USD 9.68 billion by 2033, which emphasizes the strong performance of traditional sales methods. Online Sales, though smaller, is showing potential growth from USD 0.87 billion to USD 1.77 billion, reflecting shifts in consumer purchasing behaviors.
Blood Group Typing Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Blood Group Typing Industry
Abbott Laboratories:
Abbott Laboratories leads in diagnostics with innovative blood typing solutions, enhancing precise and timely medical response.Thermo Fisher Scientific Inc.:
Thermo Fisher Scientific provides advanced diagnostic tools and reagents, focusing on improving healthcare outcomes and diagnostics.Beckman Coulter Inc.:
Beckman Coulter specializes in developing automated systems for blood typing, contributing to efficiency and accuracy in laboratories.Grifols S.A.:
Grifols specializes in the manufacture of immunology products and is a prominent player in the blood banking and typing sector.We're grateful to work with incredible clients.
FAQs
What is the market size in 2023?
$5.60 Billion is the reported market size for 2023, as stated in the report, reflecting current demand across hospitals, laboratories and blood banking institutions.
How big is the market projected to be in 2033?
The market is forecast to reach $11.45 Billion by 2033, driven by adoption of automated and molecular typing approaches and sustained procurement by clinical end users.
What is CAGR for the forecast period?
The report states a 7.2% CAGR for the period 2023 to 2033, indicating steady year-on-year expansion supported by technology uptake and increased testing volumes.
Why is North America significant?
North America is both the largest and fastest-growing region, with market size rising from $2.09 Billion in 2023 to $4.27 Billion in 2033, supported by advanced diagnostics infrastructure.
Which companies are listed as top players?
Top companies identified include Abbott Laboratories, Thermo Fisher Scientific Inc., Beckman Coulter Inc., and Grifols S.A., noted for supplies across instruments, reagents and kits.
Who are the primary end users?
Primary end users are hospitals, laboratories and blood banking institutions, which drive demand for manual and automated typing systems as well as reagents and kits.
What are the main market segments?
The market is segmented by type (manual, automated, reagents and kits), by application (blood banks, clinical diagnostics, forensic science) and by end user.
How does technology influence growth?
Advances in automated and molecular typing increase testing speed and accuracy, prompting hospitals and blood banks to upgrade equipment and consume more reagents and kits.
Why are reagents and kits important?
Reagents and kits enable both manual and automated workflows; demand for these consumables grows alongside increased testing volumes in clinical and blood banking settings.